FI882081A0 - 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning. - Google Patents
2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.Info
- Publication number
- FI882081A0 FI882081A0 FI882081A FI882081A FI882081A0 FI 882081 A0 FI882081 A0 FI 882081A0 FI 882081 A FI882081 A FI 882081A FI 882081 A FI882081 A FI 882081A FI 882081 A0 FI882081 A0 FI 882081A0
- Authority
- FI
- Finland
- Prior art keywords
- optionally substituted
- fusionerade
- pyrimidiner
- triazolo
- substitute
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91317386A | 1986-09-30 | 1986-09-30 | |
US91317386 | 1986-09-30 | ||
US2005587 | 1987-02-27 | ||
US07/020,055 US4831013A (en) | 1986-03-20 | 1987-02-27 | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof |
EP8700547 | 1987-09-25 | ||
PCT/EP1987/000547 WO1988002370A1 (en) | 1986-09-30 | 1987-09-25 | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines pharmaceutical compositions and uses thereof |
CN89106168A CN1049120A (zh) | 1986-09-30 | 1989-08-03 | 制取合成材料的方法 |
CN89106168 | 1989-08-03 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI882081A0 true FI882081A0 (fi) | 1988-05-04 |
FI882081A FI882081A (fi) | 1988-05-04 |
FI86727B FI86727B (fi) | 1992-06-30 |
FI86727C FI86727C (fi) | 1992-10-12 |
Family
ID=36741346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI882081A FI86727C (fi) | 1986-09-30 | 1988-05-04 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-fenyl- eller halogenfenyl-7,8,9,10-tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrimidoner |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0263071B1 (fi) |
JP (1) | JPH06104666B2 (fi) |
CN (1) | CN1049120A (fi) |
AT (1) | ATE79380T1 (fi) |
AU (1) | AU612331B2 (fi) |
CA (1) | CA1317590C (fi) |
DE (1) | DE3781080T2 (fi) |
DK (1) | DK289888D0 (fi) |
ES (1) | ES2051772T3 (fi) |
FI (1) | FI86727C (fi) |
GR (1) | GR3006247T3 (fi) |
IE (1) | IE59815B1 (fi) |
WO (1) | WO1988002370A1 (fi) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1331178C (en) * | 1988-02-05 | 1994-08-02 | James J. Wade | Triazolo ¬1,5-c| pyrimido ¬1,4| azines as bronchodilators |
US5173492A (en) * | 1989-09-14 | 1992-12-22 | Kyowa Hakko Kogyo Co., Ltd. | s-Triazolo(3,4-I)purine derivatives |
CA2029651C (en) * | 1989-11-17 | 2000-06-06 | David D. Davey | Tricyclic pteridinones and a process for their preparation |
US5095015A (en) * | 1990-07-24 | 1992-03-10 | Neurogen Corporation | Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
US5185446A (en) * | 1990-09-04 | 1993-02-09 | Neurogen Corporation | Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands |
US5206222A (en) * | 1991-05-22 | 1993-04-27 | Vanderbilt University | Methods for the reduction of myocardial reperfusion injury |
GB9111130D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Azole derivatives |
GB9111131D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Heterocyclic compounds |
GB9125002D0 (en) * | 1991-11-25 | 1992-01-22 | Ici Plc | Azole derivatives |
IT1264901B1 (it) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
DE69428977T2 (de) * | 1993-07-27 | 2002-07-11 | Kyowa Hakko Kogyo Kk | Arzneimittel gegen Parkinsonsche Krankheit |
US5955465A (en) * | 1996-03-22 | 1999-09-21 | Neurogen Corporation | 1,2,4-triazolo 4,3-c!quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones |
US5677309A (en) * | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
CN1060698C (zh) * | 1996-04-26 | 2001-01-17 | 清华大学 | 可完成多种快速原型制造工艺的多功能设备 |
CN1061279C (zh) * | 1996-06-21 | 2001-01-31 | 李琎 | 制造铁铝或铁三铝金属间化合物零件的方法 |
AU743910B2 (en) * | 1997-03-24 | 2002-02-07 | Kyowa Hakko Kirin Co., Ltd. | {1,2,4}triazolo{1,5-c}pyrimidine derivatives |
KR100513062B1 (ko) * | 1998-04-03 | 2005-09-05 | 가부시키 가이샤 오오쯔카 세이야쿠 고우죠우 | 트리아조로푸린 유도체, 그 유도체를 함유하는 의약조성물, 아데노신 에이3 수용체 친화제 및 천식치료제 |
DE19826843A1 (de) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
CA2385865A1 (en) | 1999-09-28 | 2001-04-05 | Takashi Okamura | Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine a3 receptor affinitive agents |
AU2002340184B2 (en) * | 2001-10-15 | 2005-10-06 | Schering Corporation | Imidazo (4,3-E)-1,2,4-triazolo(1,5-C) pyrimidines as adenosine A2A receptor antagonists |
US7196106B2 (en) | 2002-11-05 | 2007-03-27 | Merck & Co., Inc | Cyanothiophene derivatives, compositions containing such compounds and methods of use |
BRPI0411120A (pt) * | 2003-06-10 | 2006-07-18 | Kyowa Hakko Kogyo Kk | método para tratar de um distúrbio de ansiedade, composição, agente para tratar de um distúrbio de ansiedade, e, usos de um composto e de um derivado de xantina |
WO2014101113A1 (en) * | 2012-12-28 | 2014-07-03 | Merck Sharp & Dohme Corp. | Piperazine-substituted 7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
JP7280883B2 (ja) * | 2018-08-30 | 2023-05-24 | テラ・ストーン株式会社 | キサンチンオキシダーゼを阻害するためのヒドラジノプリン化合物及びトリアゾロプリン化合物 |
EP3950064A4 (en) * | 2019-04-03 | 2023-01-04 | Tera Stone Co., Ltd | THYMINE NUCLEOBASE BASED TRIAZOLOPYRIMIDINES AND PROCESS FOR THEIR PRODUCTION |
WO2022029063A1 (en) | 2020-08-04 | 2022-02-10 | Bayer Aktiengesellschaft | Pyrido[1,2,4]triazolo[1,5-c]pyrimidin-5-amines |
CN116380599B (zh) * | 2023-06-06 | 2023-08-11 | 江苏省沙钢钢铁研究院有限公司 | 一种大尺寸非金属夹杂物的制备方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0181282A1 (de) * | 1984-10-01 | 1986-05-14 | Ciba-Geigy Ag | Triazolochinazolinverbindungen |
FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
EP0217748B1 (en) * | 1985-09-30 | 1991-02-06 | Ciba-Geigy Ag | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof |
JPS62135475A (ja) * | 1985-09-30 | 1987-06-18 | チバ−ガイギ− アクチエンゲゼルシヤフト | 2−置換−e−融合−〔1,2,4〕トリアゾロ−〔1,5−C〕ピリミジン |
-
1987
- 1987-09-25 AT AT87810560T patent/ATE79380T1/de not_active IP Right Cessation
- 1987-09-25 WO PCT/EP1987/000547 patent/WO1988002370A1/en active IP Right Grant
- 1987-09-25 DE DE8787810560T patent/DE3781080T2/de not_active Expired - Lifetime
- 1987-09-25 EP EP87810560A patent/EP0263071B1/en not_active Expired - Lifetime
- 1987-09-25 AU AU80271/87A patent/AU612331B2/en not_active Ceased
- 1987-09-25 ES ES87810560T patent/ES2051772T3/es not_active Expired - Lifetime
- 1987-09-25 JP JP62505839A patent/JPH06104666B2/ja not_active Expired - Lifetime
- 1987-09-28 CA CA000547940A patent/CA1317590C/en not_active Expired - Fee Related
- 1987-09-29 IE IE261587A patent/IE59815B1/en not_active IP Right Cessation
-
1988
- 1988-05-04 FI FI882081A patent/FI86727C/fi not_active IP Right Cessation
- 1988-05-27 DK DK289888A patent/DK289888D0/da not_active Application Discontinuation
-
1989
- 1989-08-03 CN CN89106168A patent/CN1049120A/zh active Pending
-
1992
- 1992-11-13 GR GR920401657T patent/GR3006247T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA1317590C (en) | 1993-05-11 |
AU612331B2 (en) | 1991-07-11 |
JPH06104666B2 (ja) | 1994-12-21 |
DE3781080D1 (de) | 1992-09-17 |
DK289888A (da) | 1988-05-27 |
ATE79380T1 (de) | 1992-08-15 |
GR3006247T3 (fi) | 1993-06-21 |
EP0263071B1 (en) | 1992-08-12 |
IE59815B1 (en) | 1994-04-06 |
DK289888D0 (da) | 1988-05-27 |
CN1049120A (zh) | 1991-02-13 |
WO1988002370A1 (en) | 1988-04-07 |
FI882081A (fi) | 1988-05-04 |
JPH01500996A (ja) | 1989-04-06 |
AU8027187A (en) | 1988-04-21 |
DE3781080T2 (de) | 1992-12-24 |
IE872615L (en) | 1988-03-30 |
EP0263071A1 (en) | 1988-04-06 |
FI86727B (fi) | 1992-06-30 |
ES2051772T3 (es) | 1994-07-01 |
FI86727C (fi) | 1992-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI882081A0 (fi) | 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning. | |
ATE164575T1 (de) | Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer | |
LU90711I2 (fr) | 5-(4-/2-(N-m-thyl-n-(2-pyridyl)amino)-thoxy/benzyl)-2,4-thiazolidinedione ou ses sels et d-riv-s pharmaceutiquement acceptables en particulier son sel mal-ate ou ses solvates pharmaceutiquement acceptables | |
DK0471236T3 (da) | Imidazopyridinderivater og deres anvendelse | |
DK34793D0 (da) | Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det | |
IL103944A0 (en) | Piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
ES474215A1 (es) | Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio | |
RO93855A (ro) | Procedeu pentru prepararea de arilciclobutilalchilamina | |
DE68917357D1 (de) | Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten. | |
DK183789D0 (da) | 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse | |
ZA843088B (en) | Aminoimidazolinone derivatives as h2-antagonists | |
DE69024713T2 (de) | Pyrrolo(2,1-b)thiazol-Derivate | |
MY104164A (en) | Heterocyclic compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: CIBA-GEIGY AG |